Medicaments
AssigneeSmithKline Beecham Corporation
InventorsAllen Wayne Mangel, Allison Ruth Northcutt
Life of this patent
Estimating the term…
Abstract
This invention relates to the use of 5-HT3 receptor antagonists in the treatment of nonconstipated female IBS patients.
Claims10
Use of a 5-HT3 receptor antagonist or a pharmaceutically acceptable derivative thereof in the manufacture of a medicament for the treatment of nonconstipated female IBS.
A method of treatment of nonconstipated female IBS which comprises administering an effective amount of a 5-HT3 receptor antagonist or a pharmaceutically acceptable derivative thereof.
A 5-HT3 receptor antagonist or a pharmaceutically acceptable derivative thereof for use in the treatment of nonconstipated female IBS.
Dependencies are inferred from the claim text.